Tesla, Manchester United, Ohmyhome, Target, Coya: Why These 5 Stocks Are Drawing Investor Attention Today

Zinger Key Points
  • Elon Musk has projected a challenging economic environment in the upcoming year, at the company's annual meeting of the shareholders.
  • Sheikh Jassim Bin Hamad Al Thani has reportedly submitted an increased fourth bid to buy Manchester United.
  • Target is expected to report earnings of $1.76 per share on a revenue of $25.29 billion.

U.S. markets ended in the red on Tuesday as a barrage of factors including the yet inconclusive debt ceiling limit talks between President Joe Biden and House Speaker Kevin McCarthy kept investors and traders in a cautious mode. The U.S. retail sales data for April indicated softer consumer spending while Home Depot Inc HD reduced its annual forecast. Meanwhile, the following are the five stocks that are drawing investors' attention:

1. Tesla Inc TSLA: Shares of Tesla gained over 1% in extended trading. Elon Musk on Tuesday underscored the EV-maker's profitability and projected a challenging economic environment in the upcoming year, at the company’s annual meeting of the shareholders. He also warned shareholders about the potential impact of rising interest rates on car affordability.

Also Read: Everything You Need To Know About Tesla Stock

2. Manchester United PLC MANU: Shares of the company gained 4.9% in extended trading. Sheikh Jassim Bin Hamad Al Thani has submitted an increased fourth bid to buy Manchester United which is believed to be close to GBP 5 billion, according to Sky Sports.

3. Ohmyhome Ltd OMH: Shares of the company closed 79.44% lower on Tuesday after the stock witnessed a rally on abnormally high volume the day before. The company signed a memorandum of understanding for the potential acquisition of a leading tech-enabled property management company in Singapore.

4. Target Corp TGT: Shares of the company closed 2.3% lower on Tuesday. Target is set to report its earnings on Wednesday. The company is expected to report earnings of $1.76 per share on revenue of $25.29 billion.

5. Coya Therapeutics Inc COYA: Shares of the company closed 10% higher on Tuesday. Coya Therapeutics reported results from an open-label proof-of-concept clinical study for COYA 301 in patients with Alzheimer’s disease. Treatment with COYA 301 resulted in a statistically significant improvement in cognitive function.

Read Next: Goldman Sachs’ Solomon, Pfizer’s Bourla, More CEOs Implore Biden, McCarthy To Avoid Disastrous Default

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!